way. Initially, only 45 % of the participants were able to discriminate between two 24-hour urine samples, differing in oestrogen by at least 2.0 umol, when analyses were performed on different days.
In the final period ending March 1980,61 %of participants achieved this standard.
The estimation of oestrogens in the urine of women in the last 10 weeks of pregnancy provides a valuable means of assessing the risk of intrauterine death from chronic placental insufficiency.' Normal values are reassuring in that intrauterine death is unlikely, even in the presence of disturbing clinical signs. Subnormal values indicate that intrauterine death is probable unless appropriate action is taken. There are circumstances, for example, high-dose corticosteroid therapy.s treatment with penicillin and its derivatives;" and placental sulphatase deficiency.f in which low values are found which do not necessarily indicate a high risk of subsequent stillbirth.
Induction of delivery is rarely justified on the Method basis of a single assay. If circumstances permit, the obstetrician will require evidence of a falling trend in Participants in the survey provided the following oestrogen excretion or two or three successive information on joining and agreed to notify changes: subnormal values before taking action. Conversely, (1) method of use; (2) number of specimens analysed a single normal result obtained at 30 weeks' gestation each week; (3) number of times each week that does not exclude stillbirth near term, and repeat oestrogen analyses were performed; (4) grade of staff assays will be required. Consequently, reproducible doing analyses; (5) other technical details. analyses are necessary if the laboratory is to give A sample of sterile freeze-dried urine (GS Ross proper guidance to the obstetrician.
Ltd, Macclesfield, Cheshire) was sent to laboratories With most methods in use there is little risk of at intervals of three weeks. Participants were asked to intrauterine death if the oestrogen excretion is more dissolve the material in water (S ml) and to treat this than 140 flomoljday. Risk is severe when excretion is solution as a sample of urine from a 24-hour urine less than 60 flomoljday. The outlook for the fetus collection with a volume of 2litres. Analytical results therefore changes from one of safety to one of received within two weeks of despatch were used to jeopardy within a span of 80 flomoI. On this basis it is calculate the mean, between-laboratory standard considered that laboratories should be able to detect, deviation, and coefficient of variation for all methods 311 that were used by five or more participants. This information, together with a list of all results identified by code numbers, was returned to each laboratory. At intervals of nine months an assessment of between-batch precision for each participant was made from the results returned on the 12 samples distributed during the period, which comprised duplicate samples of six specimens. The order of distribution was random and unknown to the participants. Oestrogen concentrations ranged from 15 !lmol/l to 50 urnol/I. Laboratories were required to assay at least four pairs of these duplicates by the same method to be included in the assessment.
Between-batch precision was assessed from the differences reported between individual members of the pairs of samples. An index of discrimination 6. was calculated from the equation:
where D and d are the values returned for each member of a pair and N is the number of pairs returned. This discrimination index (6.) provides a measure of the smallest difference in daily oestrogen excretion that can be detected with confidence (p = 0'05) when analyses are carried out on different days.
Results
The number of laboratories taking part varied from 140 to 160. Of these, about 90% returned analyses in time to be included in the calculations. About 130 laboratories completed sufficient pairs to be included in each nine-month period of assessment.
Proportion of laboratories (as a percentage of those assaying at least four pairs by one method) with different levels of discrimination (calculated as 2· 7 x SD) and shown as the change in daily output that can be detected with confidence when analyses are carried out on different occasions under consideration. Comparison by J: test of the proportion of laboratories with a discrimination index of <20 !lmol in the first and last assessment periods shows that this change is significant (p<0·02). The improvement appears to have occurred by a greater proportion of laboratories achieving 6. values of < 10 !lmol and a smaller proportion of laboratories having 6. values between 30 and 50 !lmo!. The intermediate groups, 6. = 10-20 umol and 20-30 !lmol, have contained a similar proportion of participants in each assessment period. This pattern of improvement is shown also in the numbers of laboratories which achieve these different levels of performance and cannot be explained by loss from the survey of participants who failed to achieve good performance. 
PRECISION ACHIEVED AS A FUNCTION OF METHOD IN USE
The discrimination index achieved by participants in the period July 1979-February 1980 related to the assay method used is shown in the Figure. A wide range of discrimination values was obtained with each method, and none gave a clearly superior or inferior performance. To this extent the imprecision found was not related to the method in use.
Discussion
This external quality assessment scheme has attempted to assess laboratory precision by considering the assay results of distributed duplicate urine samples. The assessment depends entirely on the participant's own returns and is not related to a deviation from the consensus. The survey was designed in this way because (I) for this assay between-batch precision is probably more important to clinical decision-making than is lack of bias; and (2) large between-laboratory variations were known to exist even among laboratories claiming to use a common method, which makes relation to the consensus difficult to justify. It was encouraging to find that during the past six years performance of the assay, assessed in this way, had improved. A greater degree of improvement might have been expected in view of the widespread replacement of manual methods by continuous-flow techniques. Inspection of laboratory returns, however, shows no clear association between discrimination achieved and the method in use.
A detailed questionnaire completed in 1978 5 indicated that among good performers (f':, < 10) there was a greater proportion of Lever method users than expected from the frequency of use. Also, among poor performers (f':, > 20) there were fewer users of the Lever method than might have been expected. This finding was not entirely confirmed by the more recent data in the Figure. There was no enrichment of Lever method users among good performers, but there were fewer Lever method users than expected among poor performers. There still remain the 39 % of laboratories which failed to achieve f':, values of less than 20 fLmol and which may therefore be carrying out oestrogen estimations with precision inadequate for their purpose. Five of the seven laboratories with f':, values >50 fLmol in the last survey period obtained 313 this poor result apparently because of recognisable arithmetical errors affecting one member of a pair of samples. This observation, together with the persistent failure of some laboratories to complete the reporting form fully, suggest that laboratories did not treat the quality assessment sample with any exceptional care. One is left with the impression that the commitment of the laboratory to the assay, rather than work-load, frequency of assay, grade of staff, or the particular method in use, is the key factor in laboratory performance.
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